MeSH D014917 - whooping cough
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Erythromycin | C-solve | 1993-07-30 | |||
| Erythromycin | Erythromycin | 2021-02-11 | ||||
| Erythromycin estolate | Erythromycin Estolate | 1982-01-01 | ||||
| Erythromycin lactobionate | Erythromycin Lactobionate | 1993-07-30 | ||||
| Padagis | Erythromycin | Erythromycin | 1983-09-26 | |||
| Taro Pharmaceutical | Erythromycin | A/t/s | 1982-11-18 | |||
| Mylan | Erythromycin | E-glades | 2002-03-18 | |||
| Erythromycin | Erygel | 1987-10-21 | ||||
| Erythromycin | Erythromycin | 1996-07-03 | ||||
| Erythromycin stearate | Erythromycin Stearate | 1982-01-01 | ||||
| Johnson & Johnson | Erythromycin | Erycette | 1985-02-15 | |||
| Perrigo | Guaifenesin | Guaifenesin | 2011-11-23 | |||
| Dextromethorphan, Guaifenesin | Guaifenesin Dextromethorphan | 2018-03-05 | ||||
| Pseudoephedrine, Guaifenesin | Guaifenesin Pseudoephedrine | 2022-02-01 | ||||
| Wyeth | Erythromycin lactobionate, Erythromycin stearate | Wyamycin | 1982-01-01 | |||
| Alpharma | Erythromycin | Erythromycin | 1982-04-19 | |||
| Erythromycin estolate | Erythromycin Estolate | 1982-11-18 | ||||
| Erythromycin lactobionate | Erythromycin Ethylsuccinate | 1982-01-01 |
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
100%1/1
Phase 3
80%4/5
Approved: 4Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use